In Short:
Dr Reddy’s Laboratories launched Doxycycline capsules 40 mg in the US market, which is a generic version of ORACEA. The company specified that these capsules should not be used for treating bacterial infections or preventing infections. USFDA has approved this formulation, but it is not intended for antibacterial purposes.
Exciting News from Dr. Reddy’s Laboratories!
Guess what? Dr. Reddy’s Laboratories has some fantastic news to share with all of us!
New Addition to the US Market
On Friday, the company announced the launch of Doxycycline capsules 40 mg in the US market. This drug is a therapeutic generic equivalent of ORACEA (doxycycline, USP) capsules (40 mg), which has been approved by the US Food and Drug Administration (USFDA).
Important Reminder
Dr. Reddy’s Laboratories wants to remind everyone that this formulation of doxycycline has not been evaluated for the treatment or prevention of infections. So, please do not use doxycycline capsules for treating bacterial infections, providing antibacterial prophylaxis, or reducing the numbers or eliminating microorganisms associated with any bacterial disease.
It’s always important to use medication as directed by healthcare professionals to ensure your safety and well-being.
